Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Cannabist Company Holdings Inc N.CBST

Alternate Symbol(s): N.CCHW.WT | N.CCHW | CBSTF

Healthcare Cannabis

The Cannabist Company Holdings Inc. is a cultivator, manufacturer and provider of cannabis products and related services, with operations in 13 United States jurisdictions. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The Company operates approximately 95 facilities, including 73 dispensaries and 22 cultivation and manufacturing facilities, including those under development. The Company is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The Company offers products spanning flower, edibles, oils and tablets, and manufactures brands, including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.

NEO:CBST - Post by User

Cannabist Company Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Sep 29, 2021 9:57pm

385 Views

Post# 33941833

Cultivation Operations at 34-Acre Long Island, NY Facility

One of the Largest Cultivation and Production Sites on the East Coast Will Serve the Increasing Number of New York Medical Patients with its First Harvest Planned for Q4 2021

September 29, 2021 07:00 AM Eastern Daylight Time

NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., has received approval from the New York State Department of Health to commence cultivation and processing operations at its new facility in eastern Long Island, New York. The first harvest is planned for Q4 2021.

https://www.businesswire.com/news/home/20210929005298/en/